Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 7:29 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2089–2112 of 2,513 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: RAPID Clear all

Conditions: Cannabis Use Disorder, Stimulant Use Disorder, Opioid Use Disorder, Tobacco Use Disorder, Alcohol Use Disorder, Sedative, Hypnotic, or Anxiolytic Use Disorders
Interventions: Emotional Brain Training, Standard addiction counseling and medical therapy; Behavioral · Other
Lead sponsor: Loma Linda University; Other
Eligibility: 18 Years and older
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: San Bernardino, California

Conditions: Dystonia, Focal, Task-specific
Interventions: rTMS, Sham rTMS; Device
Lead sponsor: University of Minnesota; Other
Eligibility: 21 Years to 75 Years
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Inpatient Hospitalization, Intensive Care Unit Admission, Inpatient Mortality, Sepsis and Septic Shock
Interventions: TriageGO-MDW Clinical Decision Support, Usual Care; Other
Lead sponsor: Stocastic, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 300,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 2
States / cities: Kansas City, Kansas • Kansas City, Missouri

Conditions: Respiratory Tract Infections, Influenza, Human, Common Cold
Interventions: Rapid respiratory pathogen nucleic acid amplification test; Device
Lead sponsor: University of California, Davis; Other
Eligibility: 1 Year to 101 Years
Enrollment: 194 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Epidermal Growth Factor Receptor, Non-Small Cell Lung Cancer
Interventions: Erlotinib; Drug
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 3
States / cities: Boston, Massachusetts

Conditions: Health Behavior, Diet, Healthy, Diet Habit
Interventions: Ready to Eat (RTE), Dried; Behavioral
Lead sponsor: Washington State University; Other
Eligibility: 19 Years and older
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Spokane, Washington

Conditions: HIV Infections, Sexually Transmitted Diseases, Viral, Syphilis
Interventions: mLab App Plus; Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 39 Years · Male only
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 2
States / cities: New York, New York • Nashville, Tennessee

Conditions: COVID-19, Sars-CoV-2
Interventions: Saliva Assay; Device
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 5 Years and older
Enrollment: 464 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Healthy Volunteer
Interventions: RO4917523; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013
U.S. locations: 1
States / cities: Marlton, New Jersey

Conditions: Normal and Overweight Individuals at High-risk of Diabetes
Interventions: Fasting arm, Weight maintenance, Counseling; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 21 Years to 45 Years
Enrollment: 90 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: SpO2, Nasal Alar Collapse, Bilateral, Oxygen, Measurement
Interventions: SaO2 Sampling; Device
Lead sponsor: Philips Clinical & Medical Affairs Global; Industry
Eligibility: Not listed
Enrollment: 560 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 5
States / cities: Phoenix, Arizona • Omaha, Nebraska • Durham, North Carolina + 2 more

Conditions: Cataract
Interventions: Faster-timeline video and healing-attention surveys, Standard-timeline video and matched surveys; Behavioral
Lead sponsor: Harvard University; Other
Eligibility: 60 Years to 80 Years
Enrollment: 147 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 2
States / cities: Boston, Massachusetts • South Burlington, Vermont

Conditions: Healthy Volunteer
Interventions: ANG-3777 (Therapeutic Dose), ANG-3777 (Supra-therapeutic Dose), Placebo, Moxifloxacin Hydrochloride; Drug
Lead sponsor: Angion Biomedica Corp; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Parkinson Disease
Interventions: Magstim Rapid Magnetic Stimulator; Device
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 40 Years to 80 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2009
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Metastatic Non-small Cell Lung Cancer
Interventions: NovoTTF-200T, Pembrolizumab, Platinum based chemotherapy; Device · Drug
Lead sponsor: NovoCure GmbH; Industry
Eligibility: 18 Years and older
Enrollment: 734 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 38
States / cities: Birmingham, Alabama • Goodyear, Arizona • Fullerton, California + 34 more

Conditions: Sensorineural Hearing Loss
Interventions: Experimental sound coding strategy (FAST), Commercially available ACE sound coding strategy; Device
Lead sponsor: Cochlear; Industry
Eligibility: 18 Years and older
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Jansen's Metaphyseal Chondrodysplasia
Interventions: PTH-IA; Drug
Lead sponsor: National Institute of Dental and Craniofacial Research (NIDCR); NIH
Eligibility: 3 Years to 100 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Cutaneous Abscess
Interventions: Xpert MRSA/SA SSTI, Standard culture; Device · Diagnostic Test
Lead sponsor: George Washington University; Other
Eligibility: 18 Years and older
Enrollment: 252 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 2
States / cities: Washington D.C., District of Columbia • Baltimore, Maryland

Conditions: COVID-19
Interventions: Standard implementation webinar and online training, Virtual facilitation; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 99 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Iron Deficiency
Interventions: Iron sucrose; Drug
Lead sponsor: The Guthrie Clinic; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017
U.S. locations: 1
States / cities: Sayre, Pennsylvania

Conditions: Osteoarthritis, Knee
Interventions: Diet and Exercise; Behavioral
Lead sponsor: Wake Forest University; Other
Eligibility: 50 Years and older · Female only
Enrollment: 1,230 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2029
U.S. locations: 3
States / cities: Boston, Massachusetts • Chapel Hill, North Carolina • Winston-Salem, North Carolina

Conditions: Alcohol-Related Disorders, Alcohol Dependence, Alcoholism, Healthy Volunteer
Interventions: NMR-spectroscopy, Oral acamprosate; Procedure · Drug
Lead sponsor: National Institutes of Health Clinical Center (CC); NIH
Eligibility: 21 Years to 65 Years
Enrollment: 56 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2010
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS)
Interventions: Haplo-Cord Transplant, Matched Unrelated Donor Transplant; Biological · Procedure
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years and older
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Healthy
Interventions: OROS methylphenidate hydrochloride, methylphenidate hydrochloride; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 55 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Boston, Massachusetts

Search by objective public record fields.

Emotional Brain Training for Addiction Medicine Treatment - A Pilot Study

Repetitive Transcranial Magnetic Stimulation for the Treatment of Focal Hand Dystonia

Linking Novel Diagnostics With Data-Driven Clinical Decision Support in the Emergency Department

Rapid Diagnostics for Upper Respiratory Infections in the Emergency Department

Rapid Plasma Genotyping For Early Initiation Of Erlotinib In EGFR Mutant Lung Cancer

Impact of Convenience on Whole Grain Consumption

mLab App Plus: A Randomized Controlled Trial of a Mobile Health (mHealth) Intervention

Repeat Testing for SARS-CoV-2

A Study of Three Modified-Release Formulations of RO4917523 in Healthy Volunteers

The Metabolic Effects of Intermittent Fasting

Project Mountain - Comparing SpO2 and SaO2 for Accuracy

Manipulating Temporal Expectations to Accelerate Recovery After Cataract Surgery

Study Developed to Evaluate the Effect of ANG-3777 on QT/QTc Interval

Investigating the Safety of srTMS in the Treatment of Parkinson's Disease

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

Fundamental Asynchronous Stimulus Timing Sound Coding Study

Safety and Efficacy of PTH-IA

Antimicrobial Stewardship Through MRSA Diagnosis in Emergency Department (ED) Patients With Abscesses

COVID-19 Vaccine Hesitancy Counseling Intervention for Pharmacists: A Stepped-Wedge Trial

The Safety of a High-Dose, Rapid Infusion of Iron Sucrose

The Osteoarthritis Prevention Study

Acamprosate to Reduce Symptoms of Alcohol Withdrawal

The Rapid Study: Randomized Phase II Study To Expedite Allogeneic Transplant With Immediate Haploidentical Plus Unrelated Cord Donor Search Versus Matched Unrelated Donor Search For AML And High-Risk MDS Patients

Study Examining Repeat Dosing of OROS® Methylphenidate (CONCERTA®) and Immediate Release Methylphenidate in Healthy Adults